文献速递皮肤肿瘤

科罗拉多儿童防晒项目队列中3至16岁痣发育轨迹

Trajectories of Nevus Development From Age 3 to 16 Years in the Colorado Kids Sun Care Program Cohort.
PubMed 文献 · JAMA Dermatol · 2018-01-01

该纵向观察性队列研究纳入1085名1998年出生的科罗拉多青少年,每年计数全身及长期/间歇日晒部位痣数。间歇日晒部位痣数持续线性增加至16岁,西班牙裔女孩11-16岁超过男孩。

要点

  • 间歇日晒部位痣数线性增加至16岁,男孩总体累积更多痣。

核心结论

  • 青少年从幼儿期至青春中期持续面临痣发育风险,获取模式因性别、西班牙裔与非西班牙裔白人及日晒部位而异。
  • 作者认为应减少该时期紫外线暴露,尤其间歇日晒部位;男孩总体累积更多痣,女孩青春期累积较多,似应加强防晒关注。

研究设计与样本

  • annual longitudinal observational cohort study,2001年6月1日至2014年10月31日在科罗拉多州1085名青少年中开展,数据分析于2015年2月1日至2017年8月31日进行。
  • 纳入557名女孩和528名男孩(150名[13.8%]西班牙裔参与者),均出生于1998年。

主要发现

  • 非西班牙裔白人男孩全身痣中位数从3岁6.31(95%CI 5.66-7.03)线性增至16岁81.30(95%CI 75.95-87.03),女孩从3岁6.61(95%CI 5.96-7.33)增至16岁77.58(95%CI 72.68-82.81)。
  • 西班牙裔白人男孩16岁全身痣中位数51.45(95%CI 44.01-60.15),女孩53.75(95%CI 45.40-63.62),低于非西班牙裔白人儿童,但大致呈线性趋势且因性别而异。
  • 长期日晒部位痣数随时间增加但至16岁趋平;间歇日晒部位痣数至16岁呈强线性模式。
  • 西班牙裔白人男孩和女孩间歇日晒部位痣数至10岁相似,此后女孩增加更陡,11至16岁女孩痣数超过男孩。

临床怎么用

  • 作者认为应减少该时期紫外线暴露,尤其间歇日晒部位,因所有儿童该部位痣累积至青春中期。
  • 作者认为男孩总体累积更多痣,女孩青春期累积较多,似应加强防晒关注。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Nevi are a risk factor for melanoma and other forms of skin cancer, and many of the same factors confer risk for both. Understanding childhood nevus development may provide clues to possible causes and prevention of melanoma. OBJECTIVES: To describe nevus acquisition from the ages of 3 to 16 years among white youths and evaluate variation by sex, Hispanic ethnicity, and body sites that are chronically vs intermittently exposed to the sun. DESIGN, SETTING, AND PARTICIPANTS: This annual longitudinal observational cohort study of nevus development was conducted between June 1, 2001, and October 31, 2014, among 1085 Colorado youths. Data analysis was conducted between February 1, 2015, and August 31, 2017. MAIN OUTCOMES AND MEASURES: Total nevus counts on all body sites and on sites chronically and intermittently exposed to the sun separately. RESULTS: A total of 557 girls and 528 boys (150 [13.8%] Hispanic participants) born in 1998 were included in this study. Median total body nevus counts increased linearly among non-Hispanic white boys and girls between the age of 3 years (boys, 6.31; 95% CI, 5.66-7.03; and girls, 6.61; 95% CI, 5.96-7.33) and the age of 16 years (boys, 81.30; 95% CI, 75.95-87.03; and girls, 77.58; 95% CI, 72.68-82.81). Median total body nevus counts were lower among Hispanic white children (boys aged 16 years, 51.45; 95% CI, 44.01-60.15; and girls aged 16 years, 53.75; 95% CI, 45.40-63.62) compared with non-Hispanic white children, but they followed a largely linear trend that varied by sex. Nevus counts on body sites chronically exposed to the sun increased over time but leveled off by the age of 16 years. Nevus counts on sites intermittently exposed to the sun followed a strong linear pattern through the age of 16 years. Hispanic white boys and girls had similar nevus counts on sites intermittently exposed to the sun through the age of 10 years, but increases thereafter were steeper for girls, with nevus counts surpassing those of boys aged 11 to 16 years. CONCLUSIONS AND RELEVANCE: Youths are at risk for nevus development beginning in early childhood and continuing through midadolescence. Patterns of nevus acquisition differ between boys and girls, Hispanic and non-Hispanic white youths, and body sites that are chronically exposed to the sun and body sites that are intermittently exposed to the sun. Exposure to UV light during this period should be reduced, particularly on body sites intermittently exposed to the sun, where nevi accumulate through midadolescence in all children. Increased attention to sun protection appears to be merited for boys, in general, because they accumulated more nevi overall, and for girls, specifically, during the adolescent years.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Asdigian NL, Barón AE, Morelli JG, et al. Trajectories of Nevus Development From Age 3 to 16 Years in the Colorado Kids Sun Care Program Cohort. JAMA Dermatol. 2018. PMID: 30208471. doi:10.1001/jamadermatol.2018.3027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。